411 related articles for article (PubMed ID: 26276951)
1. Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block.
Paci M; Hyttinen J; Rodriguez B; Severi S
Br J Pharmacol; 2015 Nov; 172(21):5147-60. PubMed ID: 26276951
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the response of human iPSC-derived cardiomyocyte tissue to I
Dasí A; Hernández-Romero I; Gomez JF; Climent AM; Ferrero JM; Trenor B
Comput Biol Med; 2021 Oct; 137():104796. PubMed ID: 34461502
[TBL] [Abstract][Full Text] [Related]
3. Computational models of ventricular- and atrial-like human induced pluripotent stem cell derived cardiomyocytes.
Paci M; Hyttinen J; Aalto-Setälä K; Severi S
Ann Biomed Eng; 2013 Nov; 41(11):2334-48. PubMed ID: 23722932
[TBL] [Abstract][Full Text] [Related]
4. Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes.
Paci M; Casini S; Bellin M; Hyttinen J; Severi S
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428582
[TBL] [Abstract][Full Text] [Related]
5. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach.
Paci M; Passini E; Severi S; Hyttinen J; Rodriguez B
Heart Rhythm; 2017 Nov; 14(11):1704-1712. PubMed ID: 28756098
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological enhancement of repolarization reserve in human induced pluripotent stem cells derived cardiomyocytes.
Treat JA; Goodrow RJ; Bot CT; Haedo RJ; Cordeiro JM
Biochem Pharmacol; 2019 Nov; 169():113608. PubMed ID: 31465775
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes.
Lee HA; Hyun SA; Byun B; Chae JH; Kim KS
PLoS One; 2018; 13(4):e0195577. PubMed ID: 29630634
[TBL] [Abstract][Full Text] [Related]
9. Recording of multiple ion current components and action potentials in human induced pluripotent stem cell-derived cardiomyocytes via automated patch-clamp.
Mann SA; Heide J; Knott T; Airini R; Epureanu FB; Deftu AF; Deftu AT; Radu BM; Amuzescu B
J Pharmacol Toxicol Methods; 2019; 100():106599. PubMed ID: 31228558
[TBL] [Abstract][Full Text] [Related]
10. Establishment of an automated patch-clamp platform for electrophysiological and pharmacological evaluation of hiPSC-CMs.
Li W; Luo X; Ulbricht Y; Wagner M; Piorkowski C; El-Armouche A; Guan K
Stem Cell Res; 2019 Dec; 41():101662. PubMed ID: 31809994
[TBL] [Abstract][Full Text] [Related]
11. Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers.
Lemoine MD; Krause T; Koivumäki JT; Prondzynski M; Schulze ML; Girdauskas E; Willems S; Hansen A; Eschenhagen T; Christ T
Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006035. PubMed ID: 29925535
[TBL] [Abstract][Full Text] [Related]
12. Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes.
Goodrow RJ; Desai S; Treat JA; Panama BK; Desai M; Nesterenko VV; Cordeiro JM
J Pharmacol Toxicol Methods; 2018; 90():19-30. PubMed ID: 29128504
[TBL] [Abstract][Full Text] [Related]
13. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.
Ma J; Guo L; Fiene SJ; Anson BD; Thomson JA; Kamp TJ; Kolaja KL; Swanson BJ; January CT
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2006-17. PubMed ID: 21890694
[TBL] [Abstract][Full Text] [Related]
14. Effects of Electrical Stimulation on hiPSC-CM Responses to Classic Ion Channel Blockers.
Wei F; Pourrier M; Strauss DG; Stockbridge N; Pang L
Toxicol Sci; 2020 Apr; 174(2):254-265. PubMed ID: 32040191
[TBL] [Abstract][Full Text] [Related]
15. Ultrarapid Delayed Rectifier K
Hilderink S; Devalla HD; Bosch L; Wilders R; Verkerk AO
Front Cell Dev Biol; 2020; 8():536. PubMed ID: 32850774
[TBL] [Abstract][Full Text] [Related]
16. Patch-Clamp Recording from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Improving Action Potential Characteristics through Dynamic Clamp.
Verkerk AO; Veerman CC; Zegers JG; Mengarelli I; Bezzina CR; Wilders R
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28867785
[TBL] [Abstract][Full Text] [Related]
17. [Electrophysiological identification of human induced pluripotent stem cell-derived cardiomyocytes].
Zhang HY; Zhang TT; Machuki JO; Wu LJ; Sun H
Sheng Li Xue Bao; 2018 Jun; 70(3):281-286. PubMed ID: 29926069
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
[TBL] [Abstract][Full Text] [Related]
19. Ion Channel Expression and Electrophysiology of Singular Human (Primary and Induced Pluripotent Stem Cell-Derived) Cardiomyocytes.
Schmid C; Abi-Gerges N; Leitner MG; Zellner D; Rast G
Cells; 2021 Nov; 10(12):. PubMed ID: 34943878
[TBL] [Abstract][Full Text] [Related]
20. Resolving the Reversed Rate Effect of Calcium Channel Blockers on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and the Impact on In Vitro Cardiac Safety Evaluation.
Zeng H; Wang J; Clouse H; Lagrutta A; Sannajust F
Toxicol Sci; 2019 Feb; 167(2):573-580. PubMed ID: 30365015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
